Peroxisome proliferator–activated receptor γ coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease
A critical question related to the deactivation of mitochondrial metabolism in heart failure is
whether such energy metabolic abnormalities contribute to the pathology of, or are …
whether such energy metabolic abnormalities contribute to the pathology of, or are …
Safety issues and prospects for future generations of PPAR modulators
A Rubenstrunk, R Hanf, DW Hum, JC Fruchart… - … et Biophysica Acta (BBA …, 2007 - Elsevier
Because of their wide range of actions on glucose homeostasis, lipid metabolism and
vascular inflammation, peroxisome proliferator-activated receptors (PPARs) are promising …
vascular inflammation, peroxisome proliferator-activated receptors (PPARs) are promising …
Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity
PJ O'Brien - Toxicology, 2008 - Elsevier
There is an overwhelming weight of evidence that certifies cardiac troponin (cTn) as the
preferred, defacto, translational, safety biomarker for myocardial injury in cardiotoxicity. As …
preferred, defacto, translational, safety biomarker for myocardial injury in cardiotoxicity. As …
[图书][B] Animal clinical chemistry: a practical handbook for toxicologists and biomedical researchers
GO Evans - 2009 - taylorfrancis.com
10+ Years of Updates Since First EditionNewcomers to the animal clinical chemistry and
toxicology fields quickly find that the same rules of human medicine do not always apply …
toxicology fields quickly find that the same rules of human medicine do not always apply …
Cardiac hypertrophy is enhanced in PPARα−/− mice in response to chronic pressure overload
PJH Smeets, BEJ Teunissen… - Cardiovascular …, 2008 - academic.oup.com
Aims Peroxisome proliferator-activated receptor-α (PPARα) is a nuclear receptor regulating
cardiac metabolism that also has anti-inflammatory properties. Since the activation of …
cardiac metabolism that also has anti-inflammatory properties. Since the activation of …
[PDF][PDF] Modulation of cardiac ryanodine receptor activity by ROS and RNS
Introduction 3. Molecular basis of RyR2 redox regulation 3.1. Nitric Oxide Synthases and
RyR2 S-Nitrosylation 3.1. 1. Localization and function of NOS isoforms in cardiac myocytes …
RyR2 S-Nitrosylation 3.1. 1. Localization and function of NOS isoforms in cardiac myocytes …
Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization
DN Brindley, BPC Kok… - American Journal …, 2010 - journals.physiology.org
Excessive fatty acid (FA) uptake by cardiac myocytes is often associated with adverse
changes in cardiac function. This is especially evident in diabetic individuals, where …
changes in cardiac function. This is especially evident in diabetic individuals, where …
[图书][B] The clinical chemistry of laboratory animals
DM Kurtz, GS Travlos - 2017 - books.google.com
Key features: Serves as the detailed, authoritative source of the clinical chemistry of the most
commonly used laboratory animals Includes detailed chapters dedicated to descriptions of …
commonly used laboratory animals Includes detailed chapters dedicated to descriptions of …
Mitochondria and oxidative stress in the cardiorenal metabolic syndrome
AR Aroor, C Mandavia, J Ren, JR Sowers… - Cardiorenal …, 2012 - karger.com
Mitochondria play a fundamental role in the maintenance of normal structure, function, and
survival of tissues. There is considerable evidence for mitochondrial dysfunction in …
survival of tissues. There is considerable evidence for mitochondrial dysfunction in …
Relationship between epigenetic regulation, dietary habits, and the developmental origins of health and disease theory
K Mochizuki, N Hariya, K Honma… - Congenital …, 2017 - Wiley Online Library
Environmental stressors during developmental stages are hypothesized to increase the risk
of developing metabolic diseases such as obesity, type 2 diabetes, hypertension, and …
of developing metabolic diseases such as obesity, type 2 diabetes, hypertension, and …